Enhancement of Radiosensitization by Silver Nanoparticles Functionalized with Polyethylene Glycol and Aptamer As1411 for Glioma Irradiation Therapy

References

• Brodbelt A, Greenberg D, Winters T, Williams M, Vernon S, Collins VP. Glioblastoma in England: 2007–2011. Eur J Cancer. 2015;51(4):533–542. doi:10.1016/j.ejca.2014.12.01425661102
   PubMed Web of Science ®Google Scholar
• Louis DN, Perry A, Reifenberger G, et al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 2016;131(6):803–820. doi:10.1007/s00401-016-1545-127157931
   PubMed Web of Science ®Google Scholar
• Pessina F, Navarria P, Cozzi L, et al. Value of surgical resection in patients with newly diagnosed grade III glioma treated in a multimodal approach: surgery, chemotherapy and radiotherapy. Ann Surg Oncol. 2016;23(9):3040–3046. doi:10.1245/s10434-016-5222-327072998
   PubMed Web of Science ®Google Scholar
• Shen H, Hau E, Joshi S, Dilda PJ, McDonald KL. Sensitization of glioblastoma cells to irradiation by modulating the glucose metabolism. Mol Cancer Ther. 2015;14(8):1794–1804. doi:10.1158/1535-7163.MCT-15-024726063767
   PubMed Web of Science ®Google Scholar
• Kwatra D, Venugopal A, Anant S. Nanoparticles in radiation therapy: a summary of various approaches to enhance radiosensitization in cancer. Transl Cancer Res. 2013;2(4):330–342. doi:10.3978/j.issn.2218-676X.2013.08.06
   Web of Science ®Google Scholar
• Kim JH, Jenrow KA, Brown SL. Mechanisms of radiation-induced normal tissue toxicity and implications for future clinical trials. Radiat Oncol J. 2014;32(3):103–115. doi:10.3857/roj.2014.32.3.10325324981
   PubMedGoogle Scholar
• Liu P, Huang Z, Chen Z, et al. Silver nanoparticles: a novel radiation sensitizer for glioma? Nanoscale. 2013;5(23):11829–11836. doi:10.1039/c3nr01351k24126539
   PubMed Web of Science ®Google Scholar
• Ma N, Wu F, Zhang X, et al. Shape-dependent radiosensitization effect of gold nanostructures in cancer radiotherapy: comparison of gold nanoparticles, nanospikes, and nanorods. ACS Appl Mater Interfaces. 2017;9(15):13037–13048. doi:10.1021/acsami.7b0111228338323
   PubMed Web of Science ®Google Scholar
• Dimitriou NM, Tsekenis G, Balanikas EC, et al. Gold nanoparticles, radiations and the immune system: current insights into the physical mechanisms and the biological interactions of this new alliance towards cancer therapy. Pharmacol Ther. 2017;178:1–17. doi:10.1016/j.pharmthera.2017.03.00628322970
   PubMed Web of Science ®Google Scholar
• Spyratou E, Makropoulou M, Efstathopoulos EP, Georgakilas AG, Sihver L. Recent advances in cancer therapy based on dual mode gold nanoparticles. Cancers (Basel). 2017;9:12. doi:10.3390/cancers9120173
   PubMed Web of Science ®Google Scholar
• Xu R, Ma J, Sun X, et al. Ag nanoparticles sensitize IR-induced killing of cancer cells. Cell Res. 2009;19(8):1031–1034. doi:10.1038/cr.2009.8919621033
   PubMed Web of Science ®Google Scholar
• Ma J, Xu R, Sun J, Zhao D, Tong J, Sun X. Nanoparticle surface and nanocore properties determine the effect on radiosensitivity of cancer cells upon ionizing radiation treatment. J Nanosci Nanotechnol. 2013;13(2):1472–1475. doi:10.1166/jnn.2013.608723646663
   PubMed Web of Science ®Google Scholar
• Liu P, Jin H, Guo Z, et al. Silver nanoparticles outperform gold nanoparticles in radiosensitizing U251 cells in vitro and in an intracranial mouse model of glioma. Int J Nanomedicine. 2016;11:5003–5014. doi:10.2147/IJN.S11547327757033
   PubMed Web of Science ®Google Scholar
• Leach MW, Rottman JB, Hock MB, Finco D, Rojko JL, Beyer JC. Immunogenicity/hypersensitivity of biologics. Toxicol Pathol. 2014;42(1):293–300. doi:10.1177/019262331351098724240973
   PubMed Web of Science ®Google Scholar
• Zhu J, Huang H, Dong S, Ge L, Zhang Y. Progress in aptamer-mediated drug delivery vehicles for cancer targeting and its implications in addressing chemotherapeutic challenges. Theranostics. 2014;4(9):931–944. doi:10.7150/thno.966325057317
   PubMed Web of Science ®Google Scholar
• Wu D, Gao Y, Qi Y, Chen L, Ma Y, Li Y. Peptide-based cancer therapy: opportunity and challenge. Cancer Lett. 2014;351(1):13–22. doi:10.1016/j.canlet.2014.05.00224836189
   PubMed Web of Science ®Google Scholar
• Guo J, Gao X, Su L, et al. Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery. Biomaterials. 2011;32(31):8010–8020. doi:10.1016/j.biomaterials.2011.07.00421788069
   PubMed Web of Science ®Google Scholar
• Li L, Hou J, Liu X, et al. Nucleolin-targeting liposomes guided by aptamer AS1411 for the delivery of siRNA for the treatment of malignant melanomas. Biomaterials. 2014;35(12):3840–3850. doi:10.1016/j.biomaterials.2014.01.01924486214
   PubMed Web of Science ®Google Scholar
• Huang Z, Jiang H, Liu P, et al. Continuous synthesis of size-tunable silver nanoparticles by a green electrolysis method and multi-electrode design for high yield. J Mater Chem A. 2015;3(5):1925–1929. doi:10.1039/C4TA06782G
   Web of Science ®Google Scholar
• Gao H, Qian J, Cao S, et al. Precise glioma targeting of and penetration by aptamer and peptide dual-functioned nanoparticles. Biomaterials. 2012;33(20):5115–5123. doi:10.1016/j.biomaterials.2012.03.05822484043
   PubMed Web of Science ®Google Scholar
• Ma N, Jiang Y, Zhang X, et al. Enhanced radiosensitization of gold nanospikes via hyperthermia in combined cancer radiation and photothermal therapy. ACS Appl Mater Interfaces. 2016;8(42):28480–28494. doi:10.1021/acsami.6b1013227689441
   PubMed Web of Science ®Google Scholar
• Murdock RC, Braydich-Stolle L, Schrand AM, Schlager JJ, Hussain SM. Characterization of nanomaterial dispersion in solution prior to in vitro exposure using dynamic light scattering technique. Toxicol Sci. 2008;101(2):239–253. doi:10.1093/toxsci/kfm24017872897
   PubMed Web of Science ®Google Scholar
• Jokerst JV, Lobovkina T, Zare RN, Gambhir SS. Nanoparticle PEGylation for imaging and therapy. Nanomedicine (Lond). 2011;6(4):715–728. doi:10.2217/nnm.11.1921718180
   PubMed Web of Science ®Google Scholar
• Dubey P, Matai I, Kumar SU, Sachdev A, Bhushan B, Gopinath P. Perturbation of cellular mechanistic system by silver nanoparticle toxicity: cytotoxic, genotoxic and epigenetic potentials. Adv Colloid Interface Sci. 2015;221:4–21. doi:10.1016/j.cis.2015.02.00725935324
   PubMed Web of Science ®Google Scholar
• Duan X, Li Y. Physicochemical characteristics of nanoparticles affect circulation, biodistribution, cellular internalization, and trafficking. Small. 2013;9(9–10):1521–1532. doi:10.1002/smll.20120139023019091
   PubMed Web of Science ®Google Scholar
• Swanner J, Mims J, Carroll DL, et al. Differential cytotoxic and radiosensitizing effects of silver nanoparticles on triple-negative breast cancer and non-triple-negative breast cells. Int J Nanomedicine. 2015;10:3937–3953. doi:10.2147/IJN.S8034926185437
   PubMed Web of Science ®Google Scholar
• Ba H, Rodriguez-Fernandez J, Stefani FD, Feldmann J. Immobilization of gold nanoparticles on living cell membranes upon controlled lipid binding. Nano Lett. 2010;10(8):3006–3012. doi:10.1021/nl101454a20614869
   PubMedGoogle Scholar
• Antosh MP, Wijesinghe DD, Shrestha S, et al. Enhancement of radiation effect on cancer cells by gold-pHLIP. Proc Natl Acad Sci U S A. 2015;112(17):5372–5376. doi:10.1073/pnas.150162811225870296
   PubMed Web of Science ®Google Scholar
• Li H, Du J, Du X, et al. Stimuli-responsive clustered nanoparticles for improved tumor penetration and therapeutic efficacy. Proc Natl Acad Sci U S A. 2016;113(15):4164–4169. doi:10.1073/pnas.152208011327035960
   PubMed Web of Science ®Google Scholar
• Lai Y, Chiang C, Kao T, Chen S. Dual-drug nanomedicine with hydrophilic F127-modified magnetic nanocarriers assembled in amphiphilic gelatin for enhanced penetration and drug delivery in deep tumor tissue. Int J Nanomedicine. 2018;13:3011–3026. doi:10.2147/IJN.S16131429861633
   PubMed Web of Science ®Google Scholar
• Ren Y, Mu Y, Song Y, et al. A new peptide ligand for colon cancer targeted delivery of micelles. Drug Deliv. 2016;23(5):1763–1772. doi:10.3109/10717544.2015.107729326289214
   PubMed Web of Science ®Google Scholar
• Wu J, Song C, Jiang C, Shen X, Qiao Q, Hu Y. Nucleolin targeting AS1411 modified protein nanoparticle for antitumor drugs delivery. Mol Pharm. 2013;10(10):3555–3563. doi:10.1021/mp300686g23679916
   PubMedGoogle Scholar
• Cao C, Zhang J, Wen X, et al. Metamaterials-based label-free nanosensor for conformation and affinity biosensing. ACS Nano. 2013;7(9):7583–7591. doi:10.1021/nn401645t23952283
   PubMedGoogle Scholar
• Hovanessian AG, Soundaramourty C, El KD, Nondier I, Svab J, Krust B. Surface expressed nucleolin is constantly induced in tumor cells to mediate calcium-dependent ligand internalization. PLoS One. 2010;5(12):e15787. doi:10.1371/journal.pone.001578721203423
   PubMed Web of Science ®Google Scholar
• Goswami N, Luo Z, Yuan X, Leong DT, Xie J. Engineering gold-based radiosensitizers for cancer radiotherapy. Mater Horiz. 2017;4(5):817–831. doi:10.1039/c7mh00451f
   Web of Science ®Google Scholar
• Hadjidemetriou M, Al-Ahmady Z, Kostarelos K. Time-evolution of in vivo protein corona onto blood-circulating PEGylated liposomal doxorubicin (DOXIL) nanoparticles. Nanoscale. 2016;8(13):6948–6957. doi:10.1039/c5nr09158f26961355
   PubMed Web of Science ®Google Scholar
• Chiu C, Chung T, Chen S, Ma Y. Effects of PEGylation on capture of dextran-coated magnetic nanoparticles in microcirculation. Int J Nanomedicine. 2019;14:4767–4780. doi:10.2147/IJN.S20484431308657
   PubMed Web of Science ®Google Scholar
• Muhamad N, Plengsuriyakarn T, Na-Bangchang K. Application of active targeting nanoparticle delivery system for chemotherapeutic drugs and traditional/herbal medicines in cancer therapy: a systematic review. Int J Nanomedicine. 2018;13:3921–3935. doi:10.2147/IJN.S16521030013345
   PubMed Web of Science ®Google Scholar
• Li R, Zheng K, Yuan C, Chen Z, Huang M. Be active or not: the relative contribution of active and passive tumor targeting of nanomaterials. Nanotheranostics. 2017;1(4):346–357. doi:10.7150/ntno.1938029071198
   PubMedGoogle Scholar
• Gerweck LE, Wakimoto H. At the crossroads of cancer stem cells, radiation biology, and radiation oncology. Cancer Res. 2016;76(5):994–998. doi:10.1158/0008-5472.CAN-15-245526880806
   PubMedGoogle Scholar
• Su X, Liu P, Wu H, Gu N. Enhancement of radiosensitization by metal-based nanoparticles in cancer radiation therapy. Cancer Biol Med. 2014;11(2):86–91. doi:10.7497/j.issn.2095-3941.2014.02.00325009750
   PubMedGoogle Scholar
• Coulter JA, Jain S, Butterworth KT, et al. Cell type-dependent uptake, localization, and cytotoxicity of 1.9 nm gold nanoparticles. Int J Nanomedicine. 2012;7:2673–2685. doi:10.2147/IJN.S3175122701316
   PubMed Web of Science ®Google Scholar
• Taupin F, Flaender M, Delorme R, et al. Gadolinium nanoparticles and contrast agent as radiation sensitizers. Phys Med Biol. 2015;60(11):4449–4464. doi:10.1088/0031-9155/60/11/444925988839
   PubMed Web of Science ®Google Scholar
• Lin Y, McMahon SJ, Scarpelli M, Paganetti H, Schuemann J. Comparing gold nano-particle enhanced radiotherapy with protons, megavoltage photons and kilovoltage photons: a Monte Carlo simulation. Phys Med Biol. 2014;59(24):7675–7689. doi:10.1088/0031-9155/59/24/767525415297
   PubMed Web of Science ®Google Scholar
• Youkhana EQ, Feltis B, Blencowe A, Geso M. Titanium dioxide nanoparticles as radiosensitisers: an in vitro and phantom-based study. Int J Med Sci. 2017;14(6):602–614. doi:10.7150/ijms.1905828638277
   PubMedGoogle Scholar
• Kong T, Zeng J, Wang X, et al. Enhancement of radiation cytotoxicity in breast-cancer cells by localized attachment of gold nanoparticles. Small. 2008;4(9):1537–1543. doi:10.1002/smll.20070079418712753
   PubMed Web of Science ®Google Scholar
• Zhang Y, Feng Y, Ming X, Deng J. Energy modulated photon radiotherapy: a Monte Carlo feasibility study. Biomed Res Int. 2016;2016:7319843. doi:10.1155/2016/731984326977413
   PubMedGoogle Scholar
• Hwang C, Kim JM, Kim J. Influence of concentration, nanoparticle size, beam energy, and material on dose enhancement in radiation therapy. J Radiat Res. 2017;58(4):405–411. doi:10.1093/jrr/rrx00928419319
   PubMedGoogle Scholar
• Chang M, Shiau A, Chen Y, Chang C, Chen H, Wu C. Increased apoptotic potential and dose-enhancing effect of gold nanoparticles in combination with single-dose clinical electron beams on tumor-bearing mice. Cancer Sci. 2008;99(7):1479–1484. doi:10.1111/j.1349-7006.2008.00827.x18410403
   PubMed Web of Science ®Google Scholar
• Teraoka S, Kakei Y, Akashi M, et al. Gold nanoparticles enhance X-ray irradiation-induced apoptosis in head and neck squamous cell carcinoma in vitro. Biomed Rep. 2018;9(5):415–420. doi:10.3892/br.2018.114230345038
   PubMedGoogle Scholar